ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Tells CCOPs To Slow Patient Accrual To Clinical Trials, Prepare For Budget Cuts.

May 12, 2006

First TIL Results: Four Patients, All Responded, One Complete; Panel Pens Reauthorization Drive

November 27, 1987

Final Issue Of 1984

December 13, 1984

Cancer center investigators share Nobel Prizes in medicine, chemistry.

October 8, 2004

Clinton Budget Proposes Increase For AIDS, tuberculosis, In FY94

April 23, 1993

Scientific Program Organized For XIIIth Cancer Congress

October 2, 1981